|

VX-880 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Formerly known as STx-02, Zimislecel

Pipeline

Phase 3: 1

Top Sponsors

  • Vertex Pharmaceuticals Incorporated1

Indications

  • Severe Hypoglycemia1
  • Impaired Hypoglycemic Awareness1
  • Diabetes Mellitus, Type 11
  • Diabetes1

Duarte, California1 trial

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

City of Hope

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.